Related references
Note: Only part of the references are listed.Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial (vol 17, pg 35, 2018)
I. N. van Schaik et al.
LANCET NEUROLOGY (2018)
Impact of screening and exclusion of high anti-A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital-based cohort study in the US
Carlos Martinez et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Intravenous Immunoglobulin-Induced Profound Bradycardia in a Patient With Idiopathic Thrombocytopenic Purpura
Hitesh Raheja et al.
AMERICAN JOURNAL OF THERAPEUTICS (2018)
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial
Ivo N. van Schaik et al.
LANCET NEUROLOGY (2018)
Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study
L. H. Markvardsen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Relative leucopenia and hemolytic anemia following infusion of immunoglobulin
L. K. Markvardsen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
False positive hepatitis B virus core and surface antibodies due to intravenous immunoglobulin
Nicola Benwell et al.
INTERNAL MEDICINE JOURNAL (2017)
Immunoglobulin replacement therapy in primary and secondary antibody deficiency: The correct clinical approach
Antonio Pecoraro et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Dural Venous Sinus Thrombosis and Pulmonary Embolism Following Immunoglobulin Treatment in Pediatric Patient With Immune Thrombocytopenic Purpura
Kyung Mi Park et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2017)
Passively acquired thyroid autoantibodies from intravenous immunoglobulin in autoimmune encephalitis: Two case reports
Yuto Uchida et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Renal and hematologic side effects of long-term intravenous immunoglobulin therapy in patients with neurologic disorders
Aidan A. Levine et al.
MUSCLE & NERVE (2017)
SUBCUTANEOUS VERSUS INTRAVENOUS IMMUNOGLOBULIN FOR CHRONIC AUTOIMMUNE NEUROPATHIES: A META-ANALYSIS
Juan M. Racosta et al.
MUSCLE & NERVE (2017)
Subcutaneous immunoglobulin in myasthenia gravis exacerbation A prospective, open-label trial
Grayson Beecher et al.
NEUROLOGY (2017)
Intravenous immunoglobulin for the treatment of childhood encephalitis
Mildred A. Iro et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Initial intravenous immunoglobulin doses should be based on adjusted body weight in obese patients with primary immunodeficiency disorders
Rohan Ameratunga
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2017)
Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews
Anne Louise Oaklander et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Reversible Splenial Lesion Syndrome After Intravenous Immunoglobulin Treatment for Guillain-Barre Syndrome
Elif Uygur Kucukseymen et al.
CLINICAL NEUROPHARMACOLOGY (2017)
Pharmacokinetics and Pharmacodynamics of Intravenous Immunoglobulin G Maintenance Therapy in Chronic Immune-mediated Neuropathies
W. J. R. Fokkink et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid
Kai Uwe Radomski et al.
BIODRUGS (2017)
Acute renal dysfunction caused by nonsucrose intravenous immunoglobulin in common variable immunodeficiency
Alexander S. Kim et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2017)
Transfusion Related Acute Lung Injury (TRALI): A Single Institution Experience of 15 Years
Ramesh Kumar et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2016)
Severe intravenous immunoglobulin-induced hemolysis with pigment nephropathy managed with red cell exchange
Masa Lasica et al.
JOURNAL OF CLINICAL APHERESIS (2016)
Transfusion Related Acute Lung Injury (TRALI): A Single Institution Experience of 15 Years
Ramesh Kumar et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2016)
Intravenous and subcutaneous immunoglobulin G replacement therapy
Francisco A. Bonilla
ALLERGY AND ASTHMA PROCEEDINGS (2016)
Management of adverse events in the treatment of patients with immunoglobulin therapy: A review of evidence
Patrick Cherin et al.
AUTOIMMUNITY REVIEWS (2016)
Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysis
Guillaume Moulis et al.
AUTOIMMUNITY REVIEWS (2016)
Intravenous versus subcutaneous immunoglobulin replacement in secondary hypogammaglobulinemia
Giuseppe Spadaro et al.
CLINICAL IMMUNOLOGY (2016)
Transmission of Hepatitis B Core Antibody and Galactomannan Enzyme Immunoassay Positivity via Immunoglobulin Products: A Comprehensive Analysis
Isobel Ramsay et al.
CLINICAL INFECTIOUS DISEASES (2016)
Abducens nerve palsy in a girl with incomplete Kawasaki disease
Melike Emiroglu et al.
RHEUMATOLOGY INTERNATIONAL (2016)
The Production Processes and Biological Effects of Intravenous Immunoglobulin
Ana Filipa Barahona Afonso et al.
BIOMOLECULES (2016)
Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates
Jann P. Foster et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Evidence-Based Strategies to Reduce Intravenous Immunoglobulin-Induced Headaches
Krisy-Ann Thornby et al.
ANNALS OF PHARMACOTHERAPY (2015)
Extensive cerebral venous sinus thrombosis after romiplostim treatment for immune thrombocytopenia (ITP) despite severe thrombocytopenia
P. Ho et al.
INTERNAL MEDICINE JOURNAL (2015)
Transfusion-Related Acute Lung Injury After IVIG for Myasthenic Crisis
Dereddi Raja S. Reddy et al.
NEUROCRITICAL CARE (2015)
Incidence and natural history of intravenous immunoglobulin-induced aseptic meningitis: a retrospective review at a single tertiary care center
Vighnesh Bharath et al.
TRANSFUSION (2015)
A case of circulatory collapse during intravenous immunoglobulin therapy: A manageable adverse effect!
Nicolas Charhon et al.
ANAESTHESIA CRITICAL CARE & PAIN MEDICINE (2015)
Cardiac rhythm abnormalities during intravenous immunoglobulin G(IVIG) infusion in two newborn infants: coincidence or association?
Sinan Tufekci et al.
CLINICAL CASE REPORTS (2015)
VI nerve palsy after intravenous immunoglobulin in Kawasaki disease
A. Rodriguez-Lozano et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2014)
Case report: passive transfer of hepatitis B antibodies from intravenous immunoglobulin
Simon Parker et al.
BMC INFECTIOUS DISEASES (2014)
Adverse effects of immunoglobulin G therapy: thromboembolism and haemolysis
F. A. Bonilla
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders
L. H. Markvardsen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Immediate infusion-related adverse reactions to intravenous immunoglobulin in a prospective cohort of 1765 infusions
Danielli C. Bichuetti-Silva et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases
Hirokazu Kanegane et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
Hospital-Associated Venous Thromboembolism in Children: Incidence and Clinical Characteristics
Clifford M. Takemoto et al.
JOURNAL OF PEDIATRICS (2014)
Posterior Reversible Encephalopathy Syndrome and Stroke after Intravenous Immunoglobulin Treatment in Miller-Fisher Syndrome/Bickerstaff Brain Stem Encephalitis Overlap Syndrome
Henning R. Stetefeld et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2014)
Symptomatic thromboembolic events in patients treated with intravenous-immunoglobulins: Results from a retrospective cohort study
Elena Ramirez et al.
THROMBOSIS RESEARCH (2014)
Transfusion-related acute lung injury after transfusion of pooled immune globulin: a case report
Graeme R. Quest et al.
TRANSFUSION (2014)
Intravenous immunoglobulin-induced haemolysis: a case report and review of the literature
M. J. Desborough et al.
TRANSFUSION MEDICINE (2014)
Acute aseptic meningitis due to intravenous immunoglobulin therapy in Guillain-Barree syndrome
Rajendra Singh Jain et al.
OXFORD MEDICAL CASE REPORTS (2014)
Analysis of High-dose Intravenous Immunoglobulin Therapy in 16 Patients with Refractory Autoimmune Blistering Skin Disease: High Efficacy and No Serious Adverse Events
Vera Seidling et al.
ACTA DERMATO-VENEREOLOGICA (2013)
Massive intravascular haemolysis after high dose intravenous immunoglobulin therapy
Muhajir Mohamed et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy
L. H. Markvardsen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis
Shaojie Chen et al.
HEART (2013)
Transfusion-related acute lung injury: a clinical review
Alexander P. J. Vlaar et al.
LANCET (2013)
Transfusion-related acute lung injury after intravenous immunoglobulin treatment in a lung transplant recipient
A. Stoclin et al.
VOX SANGUINIS (2013)
Thromboembolic events associated with immunoglobulin treatment
M. B. Funk et al.
VOX SANGUINIS (2013)
The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: A comprehensive review of the literature
Rima Rachid et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Efficacy, Safety and Pharmacokinetics of a Novel Subcutaneous Immunoglobulin, Evogam®, in Primary Immunodeficiency
Marianne B. Empson et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Intravenous immunoglobulin increases plasma viscosity without parallel rise in blood pressure
P. Bentley et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2012)
Pompholyx and eczematous reactions associated with intravenous immunoglobulin therapy
Meg R. Gerstenblith et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010
Gregory W. Daniel et al.
TRANSFUSION (2012)
Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study
Marianne T. Severinsen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies
Melvin Berger et al.
CLINICAL IMMUNOLOGY (2011)
Association of anti-IgA antibodies with adverse reactions to γ-globulin infusion
Rima Rachid et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Thromboembolic complications of intravenous immunoglobulin therapy in patients with neuropathy: A two-year study
Yusuf A. Rajabally et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study
Siraj A. Misbah et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2011)
Slow and steady. Reducing thrombotic events in renal transplant recipients treated with IVIg for antibody-mediated rejection
Louis Huang et al.
NEPHROLOGY (2011)
Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease
Yasushi Kemmotsu et al.
PEDIATRIC RHEUMATOLOGY (2011)
Oral immunoglobulin for the prevention of rotavirus infection in low birth weight infants
Mohan Pammi et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Not All Intravenous Immunoglobulin Preparations are Equally Well Tolerated
Laurence Feldmeyer et al.
ACTA DERMATO-VENEREOLOGICA (2010)
The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials
Yuan-Han Qin et al.
BLOOD COAGULATION & FIBRINOLYSIS (2010)
Immunoglobulin Dosage and Switch from Intravenous to Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Hypogammaglobulinemia: Decreasing Dosage Does Not Alter Serum IgG Levels
Sylvain Thepot et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Transfusion-related Acute Lung Injury During Intravenous Immunoglobulin Treatment
Paraskevi V. Voulgari et al.
JOURNAL OF RHEUMATOLOGY (2010)
Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy
Thomas Harbo et al.
NEUROLOGY (2010)
Intravenous immunoglobulin-induced neutropenia
S. Khan et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2010)
Improved Quality of Life, Immunoglobulin G Levels, and Infection Rates in Patients with Primary Immunodeficiency Diseases during Self-Treatment with Subcutaneous Immunoglobulin G
Melvin Berger et al.
SOUTHERN MEDICAL JOURNAL (2010)
Analysis of thromboembolic risk related to high-dose intravenous immunoglobulin treatment: a preliminary clinical study of 10 patients with autoimmune mucocutaneous blistering diseases
M. D. Mignogna et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2009)
Intravenous immunoglobulins-induced eczematous eruption: A long-term follow-up study
F. Cohen Aubart et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2009)
Subcutaneous immunoglobulin therapy for multifocal motor neuropathy
Filip Eftimov et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2009)
Transfusion-related acute lung injury following intravenous anti-D administration in an adolescent
Sivan Berger-Achituv et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency
Melvin Berger
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)
History of Immunoglobulin Replacement
Martha M. Eibl
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)
Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin a content
Cedric Manlhiot et al.
PEDIATRICS (2008)
Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysis
Zohra Daw et al.
TRANSFUSION (2008)
Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation
S. E. Wright et al.
TRANSPLANT INFECTIOUS DISEASE (2008)
Posterior reversible encephalopathy induced by intravenous immunoglobulin
Simohamed Belmouaz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy
Eugene Daphnis et al.
NEPHRON CLINICAL PRACTICE (2007)
Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases
Hans D. Ochs et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Intravenous immunoglobulin - Adverse effects and safe administration
H Orbach et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2005)
Single high-dose intravenous immunoglobulin therapy for Kawasaki disease increases plasma viscosity
R Baba et al.
CIRCULATION JOURNAL (2005)
Intravenous immunoglobulin-associated acute renal failure: Case series and literature review
YM Itkin et al.
PHARMACOTHERAPY (2005)
Intravenous immunoglobulin and the kidney - A two-edged sword
H Orbach et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2004)
Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency
A Aghamohammadi et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2004)
Intravenous immune globulins: an update for clinicians
I Knezevic-Maramica et al.
TRANSFUSION (2003)
Adverse effect of polyvalent immunoglobulin in the treatment of Guillain-Barre syndrome
P Chamouni et al.
TRANSFUSION AND APHERESIS SCIENCE (2003)
Neutropenia as a complication of high-dose intravenous immunoglobulin therapy in adult patients with neuroimmunologic disorders
M Matsuda et al.
CLINICAL NEUROPHARMACOLOGY (2003)
Batches of intravenous immunoglobulin associated with adverse reactions in recipients contain atypically high anti-Rh D activity
SJ Thorpe et al.
VOX SANGUINIS (2003)
SIADH and seizure associated with immunoglobulin therapy
CD Kao et al.
EUROPEAN JOURNAL OF NEUROLOGY (2003)
Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune-mediated neuropathies
TH Brannagan
NEUROLOGY (2002)
Composition and properties of IVIg preparations that affect tolerability and therapeutic efficacy
G Lemm
NEUROLOGY (2002)
Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency
S Razvi et al.
CLINICAL IMMUNOLOGY (2001)
Call for guidelines for monitoring renal function and haematological variables during intravenous infusion of immunoglobulin in neurological patients
NPS Bajaj et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Immunoglobulin as a risk factor for contrast media nephrotoxicity
N Bassilios et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
Transfusion-related acute lung injury after the infusion of IVIG
A Rizk et al.
TRANSFUSION (2001)
Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases
Y Sherer et al.
PHARMACOLOGY (2001)
Nephrotoxicity of intravenous immunoglobulin
JB Levy et al.
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS (2000)
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
HM Chapel et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2000)
Share Paper
